H.U. Group Holdings Overview
- Year Founded
-
1950
- Status
-
Public
- Employees
-
10,235
- Stock Symbol
-
4544
- Investments
-
16
- Share Price
-
$25.31
- (As of Thursday Closing)
H.U. Group Holdings General Information
Description
H U Group Holdings Inc is engaged in the contract clinical testing, manufacturing, and sales of clinical diagnostic reagents, and sterilization and surgical-related businesses. Its reportable segments are the Inspection and related services business, the Clinical diagnostic reagent business, and the Healthcare-related services business. It generates the majority of its revenue from the Inspection and related services business segment, which provides comprehensive testing services to medical institutions.
Contact Information
Website
www.hugp.comCorporate Office
- 1-8-1, Akasaka, Minato-ku
- Akasaka Intercity AIR
- Tokyo, 107-0052
- Japan
Corporate Office
- 1-8-1, Akasaka, Minato-ku
- Akasaka Intercity AIR
- Tokyo, 107-0052
- Japan
H.U. Group Holdings Stock Performance
As of 19-Nov-2026, H.U. Group Holdings’s stock price is $25.31. Its current market cap is $1.37B with 54.1M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.31 | $25.18 | $18.49 - $25.72 | $1.37B | 54.1M | 212K | $1.14 |
H.U. Group Holdings Financials Summary
As of 30-Sep-2026, H.U. Group Holdings has a trailing 12-month revenue of $1.58B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,395,399 | 1,248,570 | 1,263,969 | 1,112,085 |
| Revenue | 1,580,588 | 1,641,149 | 1,593,626 | 1,639,908 |
| EBITDA | 217,970 | 203,171 | 157,668 | 91,328 |
| Net Income | 63,285 | 45,268 | 18,105 | (52,274) |
| Total Assets | 1,644,128 | 1,673,147 | 1,868,335 | 1,921,698 |
| Total Debt | 382,814 | 464,975 | 579,061 | 541,427 |
H.U. Group Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
H.U. Group Holdings Patents
H.U. Group Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026106421-A | Platelet evaluation method, platelet measurement method, and platelet evaluation apparatus | Pending | 17-Dec-2024 | ||
| JP-2026096841-A | Information processing method, program, information processing device, and sensing device | Pending | 03-Dec-2024 | ||
| JP-2026009674-A | Information processing apparatus, computer program, information processing method, and learning model generation method | Pending | 08-Jul-2024 | ||
| JP-2026009675-A | Information processing apparatus, computer program, information processing method, and learning model generation method | Pending | 08-Jul-2024 | ||
| JP-2025163692-A | Methods for detecting polymorphism in gene having repetitive sequence polymorphism, methods for setting threshold values, methods for designing sets of detection probes, and detection probe sets | Pending | 17-Apr-2024 |
H.U. Group Holdings Signals
H.U. Group Holdings Investments & Acquisitions (16)
H.U. Group Holdings’s most recent deal was a Merger/Acquisition with Hatch Healthcare (Cervical Cancer Screening Testing Services Business). The deal was made on 16-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hatch Healthcare (Cervical Cancer Screening Testing Services Business) | 16-Dec-2024 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Medisket | 24-Mar-2022 | Joint Venture | Logistics | ||
| Micin | 26-Jan-2021 | Later Stage VC | Clinics/Outpatient Services | ||
| Cotofure | 25-Jun-2020 | Later Stage VC | Business/Productivity Software | ||
| Kringle Pharma | 07-Apr-2020 | Later Stage VC | Drug Discovery |
H.U. Group Holdings ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
20.11 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Services
Subindustry
of 97
Rank
Percentile
H.U. Group Holdings Exits (3)
H.U. Group Holdings’s most recent exit was on 22-Nov-2019 from SmartScan (Decision/Risk Analysis). The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SmartScan (Decision/Risk Analysis) | 22-Nov-2019 | Completed |
|
||
| YourBio Health | 01-Jul-2019 | Completed |
|
||
| Inform Diagnostics | 01-Nov-2011 | Merger/Acquisition | Completed |
H.U. Group Holdings Affiliates
Subsidiaries (9)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| H.U. Frontier, Inc Co. | Tokyo, Japan | 2020 | |
| Esua-Ruerusizuokagansenta-Kyoudoukensakikou | Sunto Gun Nagaizumi Cho, Japan | 2018 | |
| Japan Food Ecology Research Institute | Kobe City, Japan | 2000 | |
| Carelex | Chiyoda-ku, Japan | 1999 | |
| Advanced Life Science Institute | Tokyo, Japan | 1999 |
H.U. Group Holdings FAQs
-
When was H.U. Group Holdings founded?
H.U. Group Holdings was founded in 1950.
-
Where is H.U. Group Holdings headquartered?
H.U. Group Holdings is headquartered in Tokyo, Japan.
-
What is the size of H.U. Group Holdings?
H.U. Group Holdings has 10,235 total employees.
-
What industry is H.U. Group Holdings in?
H.U. Group Holdings’s primary industry is Diagnostic Equipment.
-
Is H.U. Group Holdings a private or public company?
H.U. Group Holdings is a Public company.
-
What is H.U. Group Holdings’s stock symbol?
The ticker symbol for H.U. Group Holdings is 4544.
-
What is the current stock price of H.U. Group Holdings?
As of 19-Nov-2026 the stock price of H.U. Group Holdings is $25.31.
-
What is the current market cap of H.U. Group Holdings?
The current market capitalization of H.U. Group Holdings is $1.37B.
-
What is H.U. Group Holdings’s current revenue?
The trailing twelve month revenue for H.U. Group Holdings is $1.58B.
-
What is H.U. Group Holdings’s annual earnings per share (EPS)?
H.U. Group Holdings’s EPS for 12 months was $1.14.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process